Provided by Tiger Trade Technology Pte. Ltd.

Toronto-Dominion Bank

120.97
+0.83000.69%
Post-market: 120.37-0.6000-0.50%19:30 EDT
Volume:1.96M
Turnover:236.11M
Market Cap:198.20B
PE:18.23
High:121.32
Open:120.93
Low:119.40
Close:120.14
52wk High:125.47
52wk Low:76.46
Shares:1.64B
Float Shares:1.61B
Volume Ratio:1.28
T/O Rate:0.12%
Dividend:3.12
Dividend Rate:2.58%
EPS(TTM):6.63
EPS(LYR):8.26
ROE:12.83%
ROA:0.78%
PB:2.21
PE(LYR):14.65

Loading ...

TD Bank Quarterly Earnings Lifted by Growth in Canada, Capital Markets Activity

Dow Jones
·
Aug 27

Toronto-Dominion Bank Q3 Adj. EPS $2.77 Beats $2.46 Estimate, Sales $16.885B Beat $14.993B Estimate

Benzinga Earnings
·
Aug 27

CrowdStrike price target raised to $250 from $235 at TD Cowen

TIPRANKS
·
Aug 27

Earnings Flash (TD) Toronto-Dominion Bank Posts Fiscal Q3 Total Revenue CA$16.89B, vs. FactSet Est of CA$15.01B

MT Newswires Live
·
Aug 27

Press Release: TD BANK GROUP Declares Dividends

Dow Jones
·
Aug 27

Veeva Systems (VEEV) Gets a Buy from TD Cowen

TIPRANKS
·
Aug 27

Toronto-Dominion Bank Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 27

Fidelity National is Maintained at Buy by TD Cowen

Dow Jones
·
Aug 26

Canada on the Cusp of an Investment Supercycle

Dow Jones
·
Aug 26

TD Synnex continues expansion of PartnerFirst

TIPRANKS
·
Aug 26

Accenture price target raised to $173 from $151 at TD Cowen

TIPRANKS
·
Aug 26

FIS price target lowered to $53 from $58 at TD Cowen

TIPRANKS
·
Aug 26

Simply Good Foods price target lowered to $11 from $13 at TD Cowen

TIPRANKS
·
Aug 26

Bank of Nova Scotia Upgraded to Buy at TD

MT Newswires Live
·
Aug 26

TD Cowen Keeps Their Hold Rating on Global Payments (GPN)

TIPRANKS
·
Aug 26

TD Cowen Upgrades Bank of Nova Scotia to Buy From Hold, CA$141 Price Target

MT Newswires Live
·
Aug 26

Scotiabank upgraded to Buy from Hold at TD Securities

TIPRANKS
·
Aug 26

H&R REIT price target lowered to C$11 from C$11.50 at TD Cowen

TIPRANKS
·
Aug 26

H&R REIT is Maintained at Buy by TD

Dow Jones
·
Aug 25

Iovance Biotherapeutics is Maintained at Buy by TD Cowen

Dow Jones
·
Aug 25